EcoR1 Capital LLC 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:58 pm Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 7,598,797 9.990% |
960,426 (+14.47%) |
Filing |
| 2023-02-10 1:48 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 6,638,371 9.900% |
2,094,924 (+46.11%) |
Filing |
| 2022-01-31 4:39 pm Purchase |
2022-01-21 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 4,543,447 6.800% |
2,770,410 (+156.25%) |
Filing |
| 2021-02-16 12:00 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 1,773,037 2.700% |
-2,468,916 (-58.20%) |
Filing |